🔎 Trials Near Me

Home › Amyloidosis › Indiana › Indianapolis

Amyloidosis clinical trials in Indianapolis, IN

3 studies for Amyloidosis are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

RecruitingObservational study
  • Research Site, Indianapolis
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT06465810

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

RecruitingPhase 3
  • Clinical Trial Site, Indianapolis
  • Clinical Trial Site, Indianapolis
Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

RecruitingPhase 3
  • Indiana University Health, Indianapolis
Ages 18 to 90 · All sexes · Updated Mar 27, 2026 · NCT06128629

About Amyloidosis

Amyloidosis is a rare condition that can affect different organs of the body. Find out about amyloidosis treatment and symptoms.

More about Amyloidosis on MedlinePlus

Amyloidosis trials in other cities

Other studies in Indianapolis

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.